![Olivier Chesnoy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Olivier Chesnoy
Amministratore Delegato presso TECHNOFLEX
Profilo
Olivier Chesnoy is currently the Chairman-Management Board at Technoflex SAS since 2011.
Prior to this, he was the Chairman & Chief Executive Officer at Theraptosis SA from 2009 to 2010.
Posizioni attive di Olivier Chesnoy
Società | Posizione | Inizio |
---|---|---|
TECHNOFLEX | Amministratore Delegato | 08/09/2011 |
Precedenti posizioni note di Olivier Chesnoy
Società | Posizione | Fine |
---|---|---|
Theraptosis SA
![]() Theraptosis SA Pharmaceuticals: MajorHealth Technology Theraptosis S.A. , a biotechnology company, was founded in April 2001. Theraptosis designs and develops various drugs that act on key apoptosis regulators to fight diseases associated with lack or excess of apoptosis including cancer and neurodegenerative diseases. The Company's key assets include a dual technology platform (CytoTrust™ and MitoTrust™) for screening and targeting purposes and a pipeline of products in the areas of CNS and oncology. Theraptosis' discovery engines integrate mitochondria, and apoptosis expertise, and has developed pre-clinical animal models. | Presidente | 10/03/2010 |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Theraptosis SA
![]() Theraptosis SA Pharmaceuticals: MajorHealth Technology Theraptosis S.A. , a biotechnology company, was founded in April 2001. Theraptosis designs and develops various drugs that act on key apoptosis regulators to fight diseases associated with lack or excess of apoptosis including cancer and neurodegenerative diseases. The Company's key assets include a dual technology platform (CytoTrust™ and MitoTrust™) for screening and targeting purposes and a pipeline of products in the areas of CNS and oncology. Theraptosis' discovery engines integrate mitochondria, and apoptosis expertise, and has developed pre-clinical animal models. | Health Technology |
Technoflex SAS
![]() Technoflex SAS Chemicals: Major DiversifiedProcess Industries Technoflex SAS engages in the design, manufacture, and marketing of flexible containers for pharmaceutical industry. Its therapeutic applications include IV therapies, cell therapy, and biopharmaceuticals. The company's products include sterile bags, multi-chamber bags, and connectors. It also provides turnkey solutions and generic drug dossiers. The company was founded by Jacques Ponlot in 1972 and is headquartered in Bidart, France. | Process Industries |
- Borsa valori
- Insiders
- Olivier Chesnoy